Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric G Meissner

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Southern Medical Journal|June 1, 2022
Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical CenterH Jensie Burton, Aastha Khatiwada, Dongjun Chung, et al.
Southern Medical Journal|June 4, 2019
Increasing Prevalence of Chronic Hepatitis C Virus Infection in a Southern Academic Obstetrical ClinicGweneth B Lazenby, Cody Orr, Constance Guille, et al.
The Journal of Infectious Diseases|September 15, 2016
Cardiovascular Disease, Statins, and HIVAllison Ross Eckard, Eric G Meissner, Inderjit Singh, et al.
Journal of Viral Hepatitis|November 2, 2018
Characterization of changes in intrahepatic immune cell populations during HCV treatment with sofosbuvir and ribavirinCody Orr, Johannes Aartun, Henry Masur, et al.
BMC Infectious Diseases|December 5, 2020
Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infectionCody Orr, Wenjie Xu, Henry Masur, et al.
Case Reports in Infectious Diseases|June 18, 2016
On-Treatment Elevation in Hepatic Transaminases during HCV Treatment with Ombitasvir, Paritaprevir, Dasabuvir, Ritonavir, and Ribavirin: A Case SeriesMadelyne Bean, Lydia Tang, Shyam Kottilil, et al.
Current HIV Research|March 30, 2004
HIV-1 replication and pathogenesis in the human thymusEric G Meissner, Karen M Duus, Rebecca Loomis, et al.
Journal of Virology|September 4, 2009
The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 EnvVijay Sivaraman, Liguo Zhang, Eric G Meissner, et al.
Virology|September 24, 2004
Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelopeEric G Meissner, Karen M Duus, Feng Gao, et al.
AIDS Research and Human Retroviruses|October 17, 2020
<i>IFNL4</i> Genotype Does Not Associate with CD4 T-Cell Recovery in People Living with Human Immunodeficiency VirusEric G Meissner, Dongjun Chung, Betty Tsao, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Southern Medical Journal|June 1, 2022
Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical CenterH Jensie Burton, Aastha Khatiwada, Dongjun Chung, et al.
Southern Medical Journal|June 4, 2019
Increasing Prevalence of Chronic Hepatitis C Virus Infection in a Southern Academic Obstetrical ClinicGweneth B Lazenby, Cody Orr, Constance Guille, et al.
The Journal of Infectious Diseases|September 15, 2016
Cardiovascular Disease, Statins, and HIVAllison Ross Eckard, Eric G Meissner, Inderjit Singh, et al.
Journal of Viral Hepatitis|November 2, 2018
Characterization of changes in intrahepatic immune cell populations during HCV treatment with sofosbuvir and ribavirinCody Orr, Johannes Aartun, Henry Masur, et al.
BMC Infectious Diseases|December 5, 2020
Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infectionCody Orr, Wenjie Xu, Henry Masur, et al.
Case Reports in Infectious Diseases|June 18, 2016
On-Treatment Elevation in Hepatic Transaminases during HCV Treatment with Ombitasvir, Paritaprevir, Dasabuvir, Ritonavir, and Ribavirin: A Case SeriesMadelyne Bean, Lydia Tang, Shyam Kottilil, et al.
Current HIV Research|March 30, 2004
HIV-1 replication and pathogenesis in the human thymusEric G Meissner, Karen M Duus, Rebecca Loomis, et al.
Journal of Virology|September 4, 2009
The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 EnvVijay Sivaraman, Liguo Zhang, Eric G Meissner, et al.
Virology|September 24, 2004
Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelopeEric G Meissner, Karen M Duus, Feng Gao, et al.
AIDS Research and Human Retroviruses|October 17, 2020
<i>IFNL4</i> Genotype Does Not Associate with CD4 T-Cell Recovery in People Living with Human Immunodeficiency VirusEric G Meissner, Dongjun Chung, Betty Tsao, et al.
Pageof 8